Cardio- renal Effect Of Dapagliflozin Alone Versus Dapagliflozin- Saxagliptin Combination In Type 2 Diabetes ( t2dm) Subjects

被引:0
|
作者
Nandula, Seshagiri Rao R.
Sen, Sabyasachi
机构
关键词
Diabetes (Type II); Endothelial progenitor cell; Extracellular matrix;
D O I
10.1161/atvb.43.suppl_1.691
中图分类号
R5 [内科学];
学科分类号
1002 ; 100201 ;
摘要
A691
引用
收藏
页数:2
相关论文
共 50 条
  • [31] Effect of dapagliflozin, saxagliptin, and the combination of both on glucagon, endogenous glucose production (EGP) and glycerol in patients with type 2 diabetes
    Sach-Friedl, S.
    Augustin, T.
    Magnes, C.
    Ekardt, E.
    Eberl, A.
    Narath, S.
    Brunner, M.
    Korsatko, S.
    Svehlikova, E.
    Treiber, G.
    Pieber, T. R.
    DIABETOLOGIA, 2017, 60 : S412 - S412
  • [32] Combination of Saxagliptin and Metformin Is Effective as Initial Therapy in Type 2 Diabetes Mellitus (T2DM) With Severe Hyperglycemia
    Babu, Ambika
    Barcham, Samih
    Daniel, Louis
    Fogelfeld, Leon
    DIABETES, 2013, 62 : A273 - A273
  • [33] Dapagliflozin combination therapy in type 2 diabetes mellitus
    Yacoub, Tamer
    POSTGRADUATE MEDICINE, 2016, 128 (01) : 124 - 136
  • [34] Pharmacokinetic drug evaluation of saxagliptin plus dapagliflozin for the treatment of type 2 diabetes
    Scheen, Andre J.
    EXPERT OPINION ON DRUG METABOLISM & TOXICOLOGY, 2017, 13 (05) : 583 - 592
  • [35] Dapagliflozin versus saxagliptin as add-on therapy in patients with type 2 diabetes inadequately controlled with metformin
    Rosenstock, Julio
    Mathieu, Chantal
    Chen, Hungta
    Garcia-Sanchez, Ricardo
    Saraiva, Gabriela Luporini
    ARCHIVES OF ENDOCRINOLOGY METABOLISM, 2018, 62 (04): : 424 - 430
  • [36] Randomised, double-blind trial of dual add-on saxagliptin plus dapagliflozin vs saxagliptin or dapagliflozin add-on alone in poorly controlled type 2 diabetes on metformin
    Hansen, L.
    Zee, P.
    Li, Y.
    Cook, W.
    Hirshberg, B.
    Iqbal, N.
    Rosenstock, J.
    DIABETOLOGIA, 2014, 57 : S8 - S8
  • [37] Effect of dapagliflozin alone and in combination with insulin in a rat model of type 1 diabetes
    Sayed, Noha
    Abdalla, Osama
    Kilany, Omnia
    Dessouki, Amina
    Yoshida, Toshinori
    Sasaki, Kazuaki
    Shimoda, Minoru
    JOURNAL OF VETERINARY MEDICAL SCIENCE, 2020, 82 (04): : 467 - 474
  • [38] Renal effects of dapagliflozin in patients with type 2 diabetes
    Thomas, Merlin C.
    THERAPEUTIC ADVANCES IN ENDOCRINOLOGY AND METABOLISM, 2014, 5 (03) : 53 - 61
  • [39] Characterization of Renal Glucose Reabsorption in Response to Dapagliflozin in Healthy Subjects and Subjects With Type 2 Diabetes
    DeFronzo, Ralph A.
    Hompesch, Marcus
    Kasichayanula, Sreeneeranj
    Liu, Xiaoni
    Hong, Ying
    Pfister, Marc
    Morrow, Linda A.
    Leslie, Bruce R.
    Boulton, David W.
    Ching, Agatha
    LaCreta, Frank P.
    Griffen, Steven C.
    DIABETES CARE, 2013, 36 (10) : 3169 - 3176
  • [40] DAPAGLIFLOZIN: COST-EFFECTIVENESS AS AN ADD-ON THERAPY TO METFORMIN IN THE TREATMENT OF TYPE 2 DIABETES (T2DM) IN ARGENTINA AND CHILE
    Elgart, J. F.
    Prestes, M.
    Gonzalez, L.
    Asteazaran, S.
    Aiello, E.
    Garrido Lecca, S.
    Alvarez, A.
    Roberts, M.
    Cortes Cuadra, P.
    Gagliardino, J. J.
    VALUE IN HEALTH, 2014, 17 (03) : A248 - A248